Immunomodulatory effects of the pentapeptide YGSRS on human peripheral-blood mononuclear cells

References

• Stanton, MM, Nelson LK, Benediktsson H, et al. Proteinase-activated receptor-1 and immunomodulatory effects of a PAR1-activating peptide in a mouse model of prostatitis. Mediators Inflamm 2013;2013:748395
   Google Scholar
• Loram LC, Culp ME, Connolly-Strong EC, Sturgill-Koszycki S. Melanocortin peptides: potential targets in systemic lupus erythematosus. Inflammation 2015;38:260--271
   Google Scholar
• Montreekachon P, Nongparn S, Sastraruji T, et al. Favorable interleukin-8 induction in human gingival epithelial cells by the antimicrobial peptide LL-37. Asian Pac J Allergy Immunol 2014;32:251–260
   Google Scholar
• Gokhale AS, Satyanarayanajois S. Peptides and peptidomimetics as immunomodulators. Immunotherapy 2014;6:755–774
   PubMed Web of Science ®Google Scholar
• Maeda M, Tanaka S, Ishizawa H, et al. Suppressive effects of peptide antibiotics against proliferation and cytokine production in mitogen-activated human peripheral-blood mononuclear cells. Arzneimittelforschung 2011;61:1–15
   Google Scholar
• Morita H, Shishido A, Matsumoto T, et al. A new immunosuppressive cyclic nonapeptide, cyclolinopeptide B from Linum usitatissimum. Bioorg Med Chem Lett 1997;7:1269–1272
   Google Scholar
• Forsythe P, Paterson S. Ciclosporin 10 years on: indications and efficacy. Vet Rec 2014;174(Suppl 2):13–21
   Google Scholar
• Hirano T, Oka K, Tamaki T. Gramicidin as a potent immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat. J Pharmacol Exp Ther 1995;273:223–229
   PubMedGoogle Scholar
• Peterson RA. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 2012;40:186–204
   PubMed Web of Science ®Google Scholar
• Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 2012;72:2162–2171
   PubMed Web of Science ®Google Scholar
• Sisirak V, Faget J, Gobert M, et al. Impaired IFN-a production by plasmacytoid dendritic cells favors regulatory T cell expansion and contributes to breast cancer progression. Cancer Res 2012;72:5188–5197
   PubMed Web of Science ®Google Scholar
• Muhetaer G, Takeuchi H, Unezaki S, et al. Clinical significance of peripheral-blood lymphocyte sensitivity to glucocorticoids for differentiation of high risk patients accompanying decreased allograft function after glucocorticoid withdrawal in renal transplantation. Clin Ther 2014;36:1264–1272
   Google Scholar
• Hirano T, Kawamura T, Fukuda S, et al. Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome. Clin Pharmacol Ther 2003;74:581–590
   Google Scholar
• Tohyama N, Tanaka S, Onda K, et al. Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen. Int Immunopharmacol 2013;15:160–166
   Google Scholar
• Hu X-M, Hirano T, Oka K. Arsenic trioxide induces apoptosis equally to T lymphoblastoid leukemia MOLT-4 cells and P-gp expressing daunorubicin-resistant MOLT-4 cells. Cancer Chemother Pharmacol 2003;51:119–126
   PubMed Web of Science ®Google Scholar
• Kamogawa S, Kagami K, Maeda M, et al. Suppressive efficacies of roxithromycin against human peripheral-blood mononuclear cells stimulated with hemolytic streptococci superantigen. Eur J Pharmacol 2009;602:439–447
   Google Scholar
• Hatanaka H, Ishizawa H, Nakamura Y, et al. Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sci 2014;99:61–68
   Google Scholar
• Masuda M, Matsumoto M, Tanaka S, et al. Clinical implication of peripheral CD4(+)CD25(+) regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 2010;225:123–131
   Google Scholar
• Ishida H, Muchamuel T, Sakaguchi S, et al. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W mice. J Exp Med 1994;179:305–310
   PubMed Web of Science ®Google Scholar
• Nicholson LB, Greer JM, Sobel RA, et al. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995;3:397–405
   PubMed Web of Science ®Google Scholar
• Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961–1966
   PubMed Web of Science ®Google Scholar
• Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1994;178:87–99
   Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235–238
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151–1164
   PubMed Web of Science ®Google Scholar
• Samstein RK, Arvey A, Josefowicz SZ, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012;151:153–166
   PubMed Web of Science ®Google Scholar